Call Us + 33 1 84 88 31 00

Article L1221-9 of the French Public Health Code

An order by the ministers responsible for health and social security sets the prices for the sale of labile blood products, with the exception of plasmas for transfusion purposes covered by 1° of article L. 1221-8. For Guadeloupe, French Guyana, Martinique, Mayotte and La Réunion and for Saint-Barthélemy and Saint-Martin, an order from the ministers responsible for overseas departments and territories, health and social security may determine increases to the…

Read More »

Article L1221-10 of the French Public Health Code

Labile blood products intended for direct therapeutic use are stored, with a view to their distribution and issue, at the Établissement Français du Sang and at the Armed Forces Blood Transfusion Centre. Health establishments and army hospitals authorised for this purpose by the administrative authority after receiving the opinion of the Établissement français du sang or, where applicable, the army blood transfusion centre, under conditions defined by decree, and the…

Read More »

Article L1221-10-1 of the French Public Health Code

The Agence nationale de sécurité du médicament et des produits de santé may, after obtaining the opinion of the Etablissement français du sang and the armed forces blood transfusion centre, regulate the use of labile blood products. The Agency may impose special conditions, restrict, suspend or prohibit their use in the interests of public health.

Read More »

Article L1221-10-2 of the French Public Health Code

Any violation in a health establishment, in an army hospital or in one of the structures mentioned in 1° to 3° of article L. 1221-10 and due to the latter, of the legislative and regulatory requirements relating to the storage of labile blood products with a view to their delivery, as well as the terms of the authorisation mentioned in the first paragraph of article L. 1221-10 , shall result…

Read More »

Article L1221-11 of the French Public Health Code

Advertising for the substances mentioned in article L. 1221-2 is prohibited. Medical information and information intended to indicate the location of depots do not constitute advertising. By way of derogation from the first paragraph, promotional communication aimed at healthcare professionals relating to plasmas in the production of which no industrial process is involved, mentioned in 1° of article L. 1221-8, is authorised under the conditions defined in chapter III of…

Read More »

Article L1221-12 of the French Public Health Code

The importation, by any organisation whatsoever, of a labile blood product or a plasma paste, for direct therapeutic use or intended for the preparation of health products, is subject to authorisation issued by the Agence nationale de sécurité du médicament et des produits de santé under conditions defined by decree. The import or export of blood, its components or derived products for scientific purposes is subject to authorisation from the…

Read More »

Article L1221-13 of the French Public Health Code

The purpose of haemovigilance is to monitor and evaluate all incidents and adverse reactions occurring in donors or recipients of labile blood products. It covers the entire transfusion chain, from the collection of labile blood products to the follow-up of recipients. Haemovigilance also includes epidemiological monitoring of donors. Health professionals, blood transfusion establishments and health establishments report and declare information relating to haemovigilance. A decree in the Conseil d’Etat shall…

Read More »

Article L1221-14 of the French Public Health Code

Victims of injury resulting from contamination by the hepatitis B or C virus or the human T-lymphotropic virus caused by a transfusion of blood products or an injection of blood-derived medicinal products carried out in the territories to which this chapter applies shall be compensated on the basis of national solidarity by the Office mentioned in Article L. 1142-22 under the conditions laid down in the second sentence of the…

Read More »

Article L1222-1 of the French Public Health Code

The Etablissement Français du Sang is a public establishment under the supervision of the Minister for Health. It is responsible for meeting the need for labile blood products and for adapting transfusion activities to medical, scientific and technological developments, while respecting ethical principles. It organises blood collection, the biological qualification of blood donations, the preparation, distribution and supply of labile blood products and their quality control throughout France, within the…

Read More »

Article L1222-1-1 of the French Public Health Code

I.-Subject to the provisions of article L. 5124-14, the Etablissement français du sang is responsible for developing all activities relating to blood transfusion, advice and monitoring transfusion procedures. As such, it may be authorised to manufacture, import and use blood-derived medicinal products as defined in b of 18° of article L. 5121-1. These activities are carried out under the responsibility of a responsible pharmacist participating in the general management of…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.